Sullivan Lara
CIK: 0001769457•President ,CEO & CMO
OfficerDirector
Primary company: Pyxis Oncology, Inc. (PYXS)
Sullivan Lara is a corporate insider (President ,CEO & CMO) at Pyxis Oncology, Inc. (PYXS) filing SEC Form 4 transactions. 21 transactions across 2 companies, totaling $0 in purchases and $81,462 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 918,308 | $0.98 | $900K | 918,308 | 3/31/2025 Filed: 4/2/2025 | Filing → | |
| Award | 1,135,000 | - | - | 1,135,000 | 12/23/2024 Filed: 12/23/2024 | Filing → | |
| Award | 1,071,242 | $3.83 | $4.10M | 1,071,242 | 3/26/2024 Filed: 3/28/2024 | Filing → | |
| Sale | 8,541 | $2.10 | $18K | 2,403,882 | 9/18/2023 Filed: 9/18/2023 | Filing → | |
| Sale | 100 | $2.25 | $225 | 2,412,423 | 9/14/2023 Filed: 9/18/2023 | Filing → | |
| Tax Payment | 184,742 | $2.13 | $394K | 2,412,523 | 9/13/2023 Filed: 9/13/2023 | Filing → | |
| Sale | 3,000 | $2.27 | $7K | 2,597,265 | 9/13/2023 Filed: 9/13/2023 | Filing → | |
| Sale | 4,917 | $2.25 | $11K | 2,600,265 | 9/12/2023 Filed: 9/13/2023 | Filing → | |
| Sale | 20,000 | $2.27 | $45K | 2,605,182 | 9/11/2023 Filed: 9/13/2023 | Filing → | |
| Award | 469,483 | $0.00 | $0 | 2,625,182 | 9/7/2023 Filed: 9/8/2023 | Filing → | |
| Award | 61,825 | - | - | 61,825 | 3/24/2023 Filed: 3/28/2023 | Filing → | |
| Award | 990,461 | - | - | 990,461 | 3/24/2023 Filed: 3/28/2023 | Filing → | |
| Disposition | 61,825 | - | - | 0 | 3/24/2023 Filed: 3/28/2023 | Filing → | |
| Disposition | 990,461 | - | - | 0 | 3/24/2023 Filed: 3/28/2023 | Filing → | |
| Award | 703,379 | $0.00 | $0 | 2,155,699 | 3/24/2023 Filed: 3/28/2023 | Filing → | |
| Award | 95,684 | $0.00 | $0 | 1,452,320 | 1/3/2023 Filed: 1/3/2023 | Filing → | |
| Award | 315,273 | $0.00 | $0 | 1,356,636 | 4/14/2022 Filed: 4/15/2022 | Filing → | |
| Award | 742,574 | $0.00 | $0 | 1,041,363 | 3/31/2022 Filed: 4/4/2022 | Filing → | |
| Award | 962,289 | $0.00 | $0 | 962,289 | 10/7/2021 Filed: 10/12/2021 | Filing → | |
REXAHN PHARMACEUTICALS, INC. RNN | Award | 3,537 | $0.00 | $0 | 3,537 | 6/6/2019 Filed: 6/7/2019 | Filing → |
Type
Award
Shares
918,308
Price
$0.98
Value
$900K
Type
Award
Shares
1,135,000
Price
-
Value
-
Type
Award
Shares
1,071,242
Price
$3.83
Value
$4.10M
Type
Sale
Shares
8,541
Price
$2.10
Value
$18K
Type
Sale
Shares
100
Price
$2.25
Value
$225
Type
Tax Payment
Shares
184,742
Price
$2.13
Value
$394K
Type
Sale
Shares
3,000
Price
$2.27
Value
$7K
Type
Sale
Shares
4,917
Price
$2.25
Value
$11K
Type
Sale
Shares
20,000
Price
$2.27
Value
$45K
Type
Award
Shares
469,483
Price
$0.00
Value
$0
Type
Award
Shares
61,825
Price
-
Value
-
Type
Award
Shares
990,461
Price
-
Value
-
Type
Disposition
Shares
61,825
Price
-
Value
-
Type
Disposition
Shares
990,461
Price
-
Value
-
Type
Award
Shares
703,379
Price
$0.00
Value
$0
Type
Award
Shares
95,684
Price
$0.00
Value
$0
Type
Award
Shares
315,273
Price
$0.00
Value
$0
Type
Award
Shares
742,574
Price
$0.00
Value
$0
Type
Award
Shares
962,289
Price
$0.00
Value
$0
REXAHN PHARMACEUTICALS, INC.
RNN
Type
Award
Shares
3,537
Price
$0.00
Value
$0
AI Agent
Try asking...